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Docosahexaenoic acid (DHA) is thought to be important for brain function. The main dietary source of DHA is fish, however, DHA can also be synthesized
from precursor omega-3 polyunsaturated fatty acids (n-3 PUFA), the most abundantly consumed being α-linolenic acid (ALA). The enzymes required to
synthesize DHA from ALA are also used to synthesize longer chain omega-6 (n-6) PUFA from linoleic acid (LNA). The large increase in LNA consumption that has
occurred over the last century has led to concern that LNA and other n-6 PUFA outcompete n-3 PUFA for enzymes involved in DHA synthesis, and therefore,
decrease overall DHA synthesis. To assess this, rats were fed diets containing LNA at 53 (high LNA diet), 11 (medium LNA diet) or 1.5% (low LNA diet) of the fatty
acids with ALA being constant across all diets (approximately 4% of the fatty acids). Rats were maintained on these diets from weaning for 8 weeks, at which
point they were subjected to a steady-state infusion of labeled ALA and LNA to measure DHA and arachidonic acid (ARA) synthesis rates. DHA and ARA synthesis
rates were generally highest in rats fed the medium and high LNA diets, while the plasma half-life of DHA was longer in rats fed the low LNA diet. Therefore,
increasing dietary LNA, in rats, did not impair DHA synthesis; however, low dietary LNA led to a decrease in DHA synthesis with tissue concentrations of DHA
possibly being maintained by a longer DHA half-life.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords: Docosahexaenoic acid; Linolenic acid; Linoleic acid; Synthesis; Kinetics; Omega-31. Introduction
Docosahexaenoic acid (DHA) is the main omega-3 polyunsaturat-
ed fatty acid (n-3 PUFA) in the brain, comprising approximately 10% of
brain fatty acids [1]. DHA is thought to be important for brain function,
and relatively lower brain DHA levels have been reported in some, but
not all, postmortem brain samples of patients with various neurolog-
ical disorders [2–9]. DHA cannot be synthesized de novo; it must either
be consumed directly from diet or synthesized from precursor n-3
PUFA. The main dietary source of DHA is fatty ﬁsh, which makes
increasing DHA consumption especially problematic in light of the
worlds collapsing ﬁsh stocks [10]. Therefore, knowing the extent to
which DHA can be synthesized from precursor n-3 PUFA is critical for
formulating dietary guidelines. Previous work performed in rats, from
our laboratory found that a diet containingα-linolenic acid (ALA), the
main precursor to DHA in human diets, was sufﬁcient to maintain☆ Funding source: Bunge Ltd. and The Natural Sciences and Engineering
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0955-2863/© 2015 The Authors. Published by Elsevier Inc. This is an open access article under tbrain DHA concentrations [11]. Moreover, rats consuming this ALA diet,
synthesized DHA at a rate that was at least threefold higher than their
brain DHA uptake and accretion rates, suggesting that DHA synthesis
from ALA was sufﬁcient to maintain brain DHA in these rats [11].
DHA is synthesized from ALA in the liver by a series of
desaturations, elongations and a β-oxidation [12,13]. Dietary DHA
has been shown to down-regulate expression of enzymes involved in
its synthesis [14]. In addition, the desaturase and elongase enzymes
act on both n-3 and omega-6 (n-6) PUFA, which may result in
competition between the two classes of PUFA for these enzymes
[12,13,15,16]. Linoleic acid (LNA) is the main n-6 PUFA in the diet and
is considered the n-6 PUFA equivalent to ALA. LNA uses the same
desaturase and elongase enzymes as ALA to be converted to
arachidonic acid (ARA), the main n-6 PUFA in the brain, and
docosapentaenoic acid n-6 (DPA n-6). Dietary intakes of LNA in the
United States have increased dramatically over the past century, due
to a 1000-fold increase in soybean oil consumption [17]. Such an
increase in LNA consumption has led to concern that LNA is
outcompeting ALA for desaturation causing a decrease in DHA
synthesis. It was recently shown that lowering dietary LNA in
human clinical trials resulted in increases in plasma phospholipid
and cholesteryl ester DHA concentrations [18,19]. While this could
indicate that DHA synthesis was higher in patients with lower LNAhe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Table 1
Percent composition of diets.
Low LNA Medium LNA High LNA
10:0 1.5±0.1 1.5±0.1 1.4±0.1
12:0 21.7±0.3 21.0±0.1 20.9±0.2
14:0 9.0±0.04 8.7±0.1 8.8±0.1
16:0 5.1±0.05 4.9±0.04 4.9±0.02
18:0 3.7±0.1 3.5±0.1 4.5±0.04
18:1n-9 53.3±0.4 44.9±0.2 2.5±0.04
18:2n-6 1.5±0.01 11.4±0.05 52.9±0.3
18:3n-3 4.2±0.02 4.0±0.02 4.2±0.01
Data shown are means (n=3) expressed as percent of total fatty acids.
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DHA in the plasma reﬂect increased secretion from the liver due to less
competition with n-6 PUFA for esteriﬁcation into lipoproteins or
increased plasma half-life. In addition, once ALA enters the liver it
must be converted to ALA-CoA in order to be synthesized to DHA,
therefore, in order for competition between ALA and LNA to have an
effect on DHA synthesis, the ALA-CoA-to-LNA-CoA ratio in the liver
must be altered. Whether or not dietary LNA can alter the ALA-to-LNA
ratio in the hepatic CoA pool is unknown. It is plausible that the CoA
pool, being about 500-fold lower than the esteriﬁed lipid pools [20], is
tightly regulated and maintained, even with extreme deprivation, by
deacylation of the esteriﬁed lipids. If diet does not alter the CoA pool, it
is possible that despite the high LNA-to-ALA ratios seen in plasmawith
high LNA diets, there will be no effect of diet on DHA synthesis.
The goal of this studywas to feed rats' diets with different amounts
of LNA and observe the effect of these diets on DHA and ARA synthesis
measured in vivo using a modiﬁed version of the steady-state infusion
method designed by Rapoport et al.[21]. We found that rats fed LNA at
a concentration of 1.5% of the fatty acids had lower DHA synthesis–
secretion rates than rats fed 53% LNA. Similar to DHA synthesis, ARA
synthesis was lowest in rats fed a low LNA diet as compared to rats fed
diets containing higher amounts of LNA. In addition, plasmaDHA half-
life was longer in rats fed 1.5% LNA compared to rats fed higher
amounts of LNA, which might explain the higher tissue DHA levels.
2. Methods
2.1. Animals
All procedures were performed in accordance with the policies set
out by the Canadian Council on Animal Care and were approved by the
Animal Ethics Committee at the University of Toronto. Three long evans
damswere ordered eachwith, 18-day-old,male, long evans pups. Dams
and pups weremaintained on standard chow, which contained no long
chain n-3 PUFA (composition reported previously [11]), for 3 days.
When pups were 21 days old, they were weaned and randomly
allocated to one of three test diets containing high,medium or low LNA.
After the rats consumed these diets for 8weeks, jugular vein and carotid
artery catheterswere surgically implanted in these rats. Threedays after
surgery, rats were infused via the jugular vein with 2H5-ALA and U-13C-
LNA for 3 h to measure the synthesis rates of longer chain PUFA.
2.2. Diets
The diets were based off the AIN93 custom low n-6 PUFA diets
(Dyets Inc, Bethlehem, PA, USA). These diets were modiﬁed such that
50% of the fatty acids were added ethyl ester oils. The ethyl ester oils
were used to control the LNA content of these diets without altering
the fatty acid content of the whole diet; therefore, these diets differed
only in their oleate and LNA content. The high LNA diet contained 50%
of the fatty acids as LNA ethyl ester (Nu-Chek Prep, Elysian, MN, USA).
The medium LNA diet contained 40% of the fatty acids as oleate ethyl
ester (Nu-Chek Prep) and 10% of the fatty acids as LNA ethyl ester. The
low LNA diet contained 50% of the fatty acids as oleate ethyl ester with
no added LNA ethyl ester. The low LNAdiet was designed to reproduce
diets used previously [22,23], and the high LNA diet was designed to
match LNA levels that are found in standard rodent chow. Full diet
fatty acid composition is found in Table 1.
2.3. Surgery
After the rats consumed their respective diets for 8 weeks, they
were subjected to surgery to implant jugular vein and carotid artery
catheters. The animals were anesthetized using isoﬂurane inhalation
(5% induction, 1–3%maintenance). Before the incision wasmade, hairwas shaved from the incision site, and the site was sterilized with
iodine and ethanol. A transverse incision was made anterior to the
upper thorax. The jugular vein was located by blunt dissection. The
veinwas isolated and tied off. The veinwas then nicked, and a catheter
(PE 50, Intramedic, Sparks, MD, USA) with a 3.5 cm silastic tubing end
(VWR, Mississauga, ON, Canada) was inserted into the vein. The
catheterwas secured using 3.0 silk suture. Next, the carotid arterywas
located and isolated by blunt dissection. The vessel was tied off and
nicked, and a catheterwas inserted 3.5 cm into the artery. The catheter
was tied to the artery using silk suture. A 16-gauge angiocath (Becton
Dickinson, Mississauga, ON, Canada) was used to guide the catheters
subcutaneously to a site outside the body near the scapula. An incision
wasmade at this site, and the catheterswere fed through a skin button
(Braintree Scientiﬁc, Braintree, MA, USA), which was then sutured to
the subcutaneous tissue at incision site. The incision site was then
sutured shut, and the catheters were tapped to the skin button for
protection. The ratswere allowed to recover from the anesthetic under
a heat lamp. One day after surgery, blood was drawn from the carotid
artery cannula (baseline blood sample) and both the jugular vein and
carotid artery catheters were locked with heparinized saline (5%
heparin by volume, Sandoz Canada Inc., Canada). The blood was
centrifuged, andplasmawas isolated and stored at−80°Cuntil analysis.
2.4. 2H5-ALA and U-
13C18-LNA Infusion
U-13C18-LNA ethyl ester (Cambridge Isotope Laboratories, Ando-
ver, MA, USA) was converted to free fatty acid by hydrolysis with 10%
KOH/Methanol at 70°C for 1 h with hexane used to extract the free
acid. Modiﬁed from Domenichiello et al. 2014 [11], infusate was made
by dissolving 4.5-μmol/100-g body weight of U-13C18-LNA (free acid)
and 2H5-ALA free acid (Cambridge Isotope Laboratories) into 5-mM
HEPES buffer (pH 7.4) containing 50-mg/ml fatty acid-free bovine
serum albumin. The infusate was mixed by sonication at 37°C. An
infusion pump (Harvard Apparatus PHD 2000; Holliston, MA, USA)
was used to infuse 3.78ml of tracer solution at a constant rate of 0.021
ml/min for 3 h into the jugular vein. Immediately before (time = 0
min) and every 30min during the infusion, 0.2 ml of bloodwas drawn
from the carotid artery, and the catheterwas ﬂushedwith heparinized
saline (5% by volume) between blood draws. After 180 min of the
infusion, 1 ml of blood was drawn from the carotid artery, and the
animals were euthanized with a lethal injection of T-61 into the
jugular vein, and livers were collected and ﬂash frozen in liquid N2. All
blood samples were centrifuged for 10 min (PC-100 microcentrifuge,
Diamed, ON, Canada), and the plasmawas collected and stored at−80°C
as previously described [11].
2.5. Plasma volume determination
Plasma volume was determined, modiﬁed from previously
described methods [11]. A known amount of Evans Blue dye was
injected into the jugular veins of the rats (n=6). After 15min, twoblood
samples of 1 ml were drawn from the carotid artery. Plasma was
collected as described above, and 0.1ml of plasmawas diluted into 1ml
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microplate absorbance reader (bio-rad laboratories, Hercules, CA,
USA), and by comparing the absorbance to a standard curve, the
concentration of the dye was determined.
2.6. Plasma lipid extraction
Lipids were extracted from 50 μl of plasma using the method of
Folch et al., 1957 [24]. For baseline plasma samples, a known amount
of heptadecanoic acid (17:0 -Nu-Check Prep. Elysian,MN) anddi-17:0
phosphatidylcholine (Nu-Check Prep.) internal standard was added.
Next, Chloroform, methanol and 0.88% KCl (4:2:1.75 v/v/v) were
added to plasma. The mixture was centrifuged, and the chloroform
phase was extracted twice. Total lipid extract (TLE) was stored under
nitrogen gas at−80°C.
2.7. Thin layer chromatography (TLC)
TLE from plasma samples were loaded onto TLC plates and run in
heptane/diethylether/glacial acetic acid (60:40:2 v/v/v) to separate
esteriﬁed and unesteriﬁed lipids, as described previously [11]. Baseline
samples were then prepared for transmethylation (described below) by
adding hexane to the esteriﬁed and unesteriﬁed fractions and storing
under nitrogen at −80°C. Infusion samples (time 0–180 min) were
prepared for LC-MS/MS (described below) by adding a known amount of
internal standard (2H8-ARA, CaymanChemical, AnnArbor,MI, USA) to the
esteriﬁedandunesteriﬁed fractions thenadding4-mlHexane/Isopropanol
(HIP, 3:2 v/v) with 5.5% dH2O and storing under nitrogen at 5°C.
2.8. Liver lipid extraction
Approximately 1 g of liverwas added to a known amount of internal
standard (2H8-ARA) and homogenized using a Polytron Benchtop
Homogenizer (Brinkman Instruments, Toronto, ON, Canada) in a
mixture of chloroform:methanol:0.88% KCl (2:1:0.8 by volume) [24].
The mixture was centrifuged at 500 g for 10 min, and the chloroform
layer was extracted. Another aliquot of chloroform was added to the
remaining aqueous phase; themixturewas once again centrifuged, and
the chloroform layer extracted and added to the previously extracted
chloroform layer then stored under N2 in−80°C until further analysis.
2.9. Transmethylation and gas chromatography–flame Ionization detection
Baseline samples were transmtehylated using 14% boron triﬂuoride
in methanol, and fatty acid methyl esters (FAME) were extracted with
hexane and quantiﬁed using gas chromatography–ﬂame ionization
detection (GC-FID) as previously described [11]. FAME were analyzed
using a Varian-430 gas chromatograph (Varian, Lake Forest, CA, USA)
equipped with a Supelco capillary column (SP-2560; 100m × 0.25 mm
i.d. × 0.20-μm ﬁlm thickness) and an FID. Samples were injected in
splitless mode. The injector and detector ports were set at 250°C. FAME
were eluted using a temperature program set initially at 60°C for 2min,
increasing at 10°C/min to 170°C, and held at 170°C for 4 min, then
increasing at 6.5°C/min to 175°C, 2.6°C/min to 185°C and 1.3°C/min to
190°C, increasing at 8°C and held at 240°C for 11 min to complete the
run at 42.71min. The carrier gas was helium, set to a constant ﬂow rate
of 3ml/min. Peakswere identiﬁed by retention times of authentic FAME
standards (Nu-Chek Prep, Inc., Elysian, MN, USA). The concentration of
each fatty acidwas calculated by comparisonwith the internal standard
(17:0) [25]. The concentrations were expressed as nmol/ml of plasma.
2.10. Fatty acyl-coA extraction
Acyl-CoAwere extracted from approximately 0.7 g of liver following
themethodofChen et al.2013 [26,27]. Brieﬂy, liverswerehomogenized,on ice, by sonication in 25-mM KH2PO4 and isopropanol. Saturated
(NH4)2SO4 was used to precipitate protein from the homogenate, and
acyl-CoA was extracted and diluted. Diluted Acyl-CoA extract was
puriﬁed using an oligonucleotide puriﬁcation cartridge (ABI Master-
piece™, OPC®; Applied Biosystems, Foster City, CA), and acyl-CoA
concentrations were measured using LC-MS/MS as described below.
2.11. Liquid chromatography-tandem mass spectrometry (LC-MS/MS)
After overnight storage, lipids were extracted from silica by
centrifuging the samples at 500 g for 10 min and transferring the HIP
phase to a new test tube (two times). Samples were evaporated under
nitrogen gas, and unesteriﬁed samples were reconstituted in 2 ml of
hexane for analysis by LC-MS/MS. Esteriﬁed plasma samples and liver
TLE were hydrolyzed with 1 ml of 10% KOH in methanol, as previously
described [11]. The hydrolyzed esteriﬁed fatty acid samples were
extracted twice with hexane, evaporated under nitrogen and recon-
stituted in 2 ml of hexane for analysis by LC-MS/MS.
Half of each plasma and liver samplewere evaporated underN2 gas
and reconstituted in 100 μl of water/acetonitrile (80:20 v/v). Fatty
acids were detected using an Agilent HPLC 1290 (Agilent Technolo-
gies, Santa Clara, CA, USA) equippedwith an Agilent Zorbax SB-Phenyl
column (3×50 mm, 3.5 μm; Agilent, Santa Clara, CA, USA). The initial
HPLC conditions of elution were set at 500-μl/min gradient system
consisting of (A) 50% water and (B) 50% acetonitrile. The gradient
started with 50% (A) and 50% (B) and maintained for 1.5 min,
increased to 100% (B) from 1.5 to 6min andmaintained at 100% B for 4
min to complete the total run of 10 min. Mass spectrometry analyses
were carried out on QTRAP 5500 triple quadruple mass spectrometer
(AB SCIEX, Framingham,MA, USA) in electrospray ionization, negative
ion mode. The source temperature was 600°C, and the ion spray
voltage was −4500 eV. The optimized parameters were as follows:
declustering potential −40 V, entrance potential −10 V, collision
energy−20 eV and collision cell exit potential−11V.Mass transitions
for 2H5-ALA, 2H5-eicosapentaenoic acid (EPA), 2H5-docosapentaenoic
acid n-3 (DPAn-3) and 2H5-DHAwere as follows: 282.2 to 59.0, 306.2 to
262.2 or 306.2 to 59.0, 334.2 to 290.2 and 332.2 to 288.2 or 332.2 to 59.0
m/z, respectively. Fatty acid concentrations were calculated by plotting
peak area ratios (fatty Acid Peak Area/Internal Standard Peak Area) of
samples against calibration curves generated from peak area ratios of
extracted standard mixes of known concentration.
2.12. Kinetic equations
To determine the DHA and ARA synthesis rates, appearance of 2H5-
DHA (or 13C18-ARA) in the plasma-esteriﬁed pool was measured and
ﬁt to a Boltzmann sigmoidal curve ([labeled-long chain PUFA]*plasma
volume vs. time) using nonlinear regression (Graphpad Prism Version
4.0, La Jolla, CA, USA) [11]. At any point on this curve, the slope (S) will
be determined by the ability of the body to synthesize labeled-long
chain PUFA from their respective labeled-precursor and the ability of
the periphery to uptake long chain PUFA (Eq. (1)).
S ¼ k
1;DHA
½2H5−ALAunesterified−k−1;DHA½2H5−DHAesterified ð1Þ
S ¼ k
1;ARA
½U−13C18−LNAunesterified−k−1;ARA½13C18−ARAesterified ð2Þ
Where k1,DHA and k1,ARA are the steady-state synthesis–secretion
coefﬁcients for DHA and ARA respectively, [2H-ALA]unesteriﬁed and
[U-13C18-LNA]unesteriﬁed are the plasma concentrations of the infu-
sates, k-1,DHA and k-1,ARA are the disappearance coefﬁcients for DHA
and ARA respectively and [2H5-DHA]esteriﬁed and [13C18-ARA]esteriﬁed
are the concentrations of DHA and ARA in the plasma that has been
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secreted into the plasma.
The maximum ﬁrst derivative (Smax) of the curves described by
Eqs. (1) and (2) is assumed to be the time point when the uptake of
esteriﬁed DHA from the periphery is negligible, that is, 0 (for example
Eq. (3)).
Smax ¼ k1;DHA½2H5−ALAunesterified−0 ð3Þ
Therefore, the derivative at this point is equal to the rate of 2H5-
DHA synthesis. By correcting the Smax by the tracee:tracer ratio, the
rats' actual DHA synthesis is determined, Jsyn,DHA (nmol/min) [11].
Jsyn;DHA ¼ Smax
ALA½ unesterified
½2H5−ALAunesterified
¼ k1;DHA ALA½ unesterified ð4Þ
Since the study diets did not contain long-chain PUFA (EPA, ARA or
DHA) and esteriﬁed plasma lipidswere constant throughout the study,
the turnover rate (Fi) and half-life (t1/2) of esteriﬁed lipids in the
plasma can be determined by Eqs. (5) and (6) (shown below) using
DHA as an example:
FDHA ¼ Jsyn;DHA
DHA½ esterifiedV plasma
ð5Þ
and
t1=2;DHA ¼ 0:693
FDHA
ð6Þ
2.13. Statistics
All data are presented asmean±S.E.M. andwere compared by one-
way ANOVA using Tukey's test for multiple comparison if ANOVA P-
value ≤0.05 (GraphPad Prism version 4.0, La Jolla, CA, USA).When data
were not normal or sample sizes were too low to test normality of the
data, determined by Kolmogrov-Smirnov normality test, then data
were log transformed and then compared by one-way ANOVA using
Tukey's test for multiple comparisons. A P-value ≤0.05 with Tukey's
multiple comparison test was considered signiﬁcant.
3. Results
3.1. Plasma volume
Mean plasma volume was 0.018±0.001 ml/g of body weight,
similar to previous estimates of long evans rat plasma volume
[11]. Plasma volume did not differ between rats fed the different
diets.
3.2. Baseline plasma unesterified lipid concentrations
Plasma unesteriﬁed ALA concentrations (Fig. 1A) were not signif-
icantly different between rats fed the different diets (5.5±1.3, 7.6±1.9,
13.3±3.1 nmol/ml for the low, medium and high LNA diet, respective-
ly). Plasma unesteriﬁed LNA concentrations (Fig. 1B) were highest in
rats fed thehigh LNAdiet but did not differ between rats fed the lowand
medium LNA diet (13.9±2.8, 31.3±6.8, 163.3±38.7 nmol/ml Pb0.05,
low, medium and high LNA diet, respectively).
3.3. Baseline plasma esterified lipid concentrations
Plasma esteriﬁed ALA concentrations (Fig. 2A) did not differ in rats
fed different diets; however, plasma esteriﬁed EPA (Fig. 2B) was
signiﬁcantly higher in rats fed the low LNA diet compared to medium
LNA diet, and rats fed the medium diet had higher plasma esteriﬁedEPA concentrations than rats fed the high LNA diets (505.3±95.7,
139.3±40.0, 27.8±2 nmol/ml low, medium and high LNA diet,
respectively, Pb0.05). Plasma esteriﬁed DHA (Fig. 2C) concentrations
were not signiﬁcantly different between rats fed either diet (506.9±
113, 274.9±39.7 nmol/ml, 304.4±37.5 nmol/ml low, medium and
high LNA diet, respectively).
Plasma esteriﬁed LNA andARA concentrations (Fig. 2D and E)were
highest in rats fed the high LNA diet. Plasma esteriﬁed ARA did not
differ between rats fed the medium and low LNA diets (2485.8±
417.5N1260±142.5=466.6±94.8 nmol/ml, Pb0.05); however, plasma
esteriﬁed LNA was signiﬁcantly higher in rats fed the medium diet
compared to rats fed the low LNA diet (2792.7±357.4, 1148±179,
654.5±109 nmol/ml low, medium and high LNA diet, respectively,
Pb0.05).
3.4. Liver fatty acid concentrations
Mean concentrations of hepatic ALA (Fig. 3A) were signiﬁcantly
higher in rats fed the medium and high LNA diets compared to those
fed the low LNA diet (378.2±62.63, 657.2±99.89, 706.6±134.4 low,
medium and high LNA diet, respectively, Pb0.05). On the contrary,
hepatic EPA andDHA concentrations (Fig. 3B and C)were signiﬁcantly
lower in rats fed the high and medium LNA diets as compared to rats
fed the low LNA diet, and hepatic EPA concentrations were lower in
rats fed the high LNAdiet as compared to rats fed themediumLNAdiet
(2836±218.9, 613.7±84.5, 160.3±16.3, nmol/g low, medium and
high LNA diet, respectively, for EPA, and 4512±329.6, 3381±215,
2684±242.5 nmol/g low, medium and high LNA diet, respectively, for
DHA, Pb0.05). Both LNA and ARA (Fig. 3D and E) were signiﬁcantly
higher in the livers of rats fed the medium and high LNA diets as
compared to those fed the low LNA diet (3627±618, 9867±720,
21114±3066 nmol/g low,mediumand high LNA diet, respectively, for
LNA, Pb0.05), and hepatic ARA concentrations were signiﬁcantly
higher in rats fed the high LNA diet as compared to rats fed the
medium LNA diet (3982±147, 11220±577, 15141±1389 nmol/g low,
medium and high LNA diet, respectively, for ARA, Pb0.05).
3.5. Plasma unesterified 2H5-ALA and
13C18-LNA concentrations
Mean concentrations of plasma unesteriﬁed 2H5-ALA throughout
the infusion were 2.9±0.3, 3.5±0.4 and 4.4±0.2 nmol/ml (low,
medium and high LNA diet, respectively) with the rats consuming the
high LNA diet having a signiﬁcantly higher 2H5-ALA concentration
than those consuming the low LNA diet (Pb0.05). Plasma unesteriﬁed
13C18-LNA concentrations were 2.4±0.4, 2.5±0.3, 1.5±0.2 nmol/ml
(low, medium and high LNA diet, respectively).
3.6. n-3 PUFA synthesis–secretion coefficients, rates, turnover rates and
half-life
Example infusion curves for one representative animal with
respective chromatograms for DHA, EPA and ARA are shown in
Fig. 4, and Table 2 shows the synthesis parameters for EPA and
DHA. For DHA, rats consuming the high LNA diet had a
signiﬁcantly higher synthesis–secretion rate than rats consuming
the low LNA diet (66.7±20.3, 369.7±91.3 nmol/day, Pb0.05),
while the synthesis–secretion rate in rats fed the medium LNA
diet did not differ from rats consuming either diet (320.5±135.8
nmol/day). K1,DHA, the synthesis–secretion coefﬁcient for DHA,
was higher in rats consuming the medium LNA diet compared to
rats consuming the low LNA diet but not different from rats
consuming the high LNA diet (0.01±0.002, 0.02±0.007, 0.02±
0.06 ml/min, low, medium and high LNA diet, respectively,
Pb0.05). DHA turnover was signiﬁcantly slower in rats consuming
the lowLNAdiet compared to rats consuming themediumandhigh LNA
Fig. 1. Plasma unesteriﬁed (A) ALA and (B) LNA concentrations (nmol/ml) in rats consuming the low, medium or high LNA diet. Plasma unesteriﬁed ALA concentrations did not differ
between rats fed the three diets, while plasma unesteriﬁed LNA concentrationswere highest in rats fed the high LNA diet but did not differ between rats fed the low ormedium LNA diet
(highNmedium=low LNA diet, Pb0.05). All data aremean±S.E.M. Different letters signify that the means are signiﬁcantly different (Pb0.05) measured by one-way ANOVA followed by
Tukey's multiple comparison test; data that were not normally distributed were log transformed. n=7,7,4 (low, medium, high LNA diet, respectively).
Fig. 2. Plasma esteriﬁed concentrations for n-3 and n-6 PUFA. (A) Plasma esteriﬁed ALA concentrations did not differ between rats fed the three diets. (B) Plasma-esteriﬁed EPA
concentrations were signiﬁcantly higher in rats fed the low LNA diet than rats fed the medium and high LNA diet (Pb0.05). (C) Plasma-esteriﬁed DHA concentrations were not
signiﬁcantly different in rats fed the three diets (PN0.05). Rats fed the high LNA diet had the highest concentrations of plasma esteriﬁed (D) LNA followed by rats consuming themedium
and low LNA diet, respectively (highNmediumNlow, Pb0.05). Plasma esteriﬁed (E) ARA concentrations were lowest in rats consuming the low LNA diet, but there were no differences in
plasma-esteriﬁed ARA between rats fed the high andmedium LNA diets. All data are mean±S.E.M. Different letters signify that themeans are signiﬁcantly different (Pb0.05) measured
by one-way ANOVA followed by Tukey's multiple comparison test; data that were not normally distributed were log transformed. n=7,7,4 (low, medium, high LNA diet, respectively).
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Fig. 3. Hepatic concentrations of n-3 andn-6 PUFA (A)hepatic ALA concentrationswere signiﬁcantlyhigher in rats fed themediumandhighLNAdiet as compared to rats fed the lowLNAdiet
(Pb0.05). (B) Hepatic EPA concentrations were lowest in rats fed the high LNA diet as compared to rats fed the medium and low LNA diet and lower in rats fed the medium LNA diet as
compared to rats fed the low LNA diet (Pb0.05). (C) Hepatic DHA concentrationswere signiﬁcantly higher in rats fed the low LNAdiet as compared to rats fed themediumand high LNAdiet
(Pb0.05). For hepatic LNA and ARA (D, E), rats fed the low LNAdiet had the lowest concentrations,while only hepatic ARA differed between rats fed themediumand high LNAdiet (Pb0.05).
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diets, respectively, Pb0.05), and half-life of DHAwas signiﬁcantly longer
in rats consuming the low LNA diet compared to rats consuming the
mediumand high LNA diet (65.0±15.5, 12.4±4.0, 6.96±3.30 days, low,
medium and high LNA diet, respectively, Pb0.05).
The daily synthesis rate for EPA was not signiﬁcantly different
between rats fed the different diets (472.6±186.3, 1339.0±423.2,
1277.8±485.9 nmol/day for rats fed the low, medium and high LNA
diet, respectively). Turnover of EPA was signiﬁcantly slower in rats
consuming the low LNA diet compared to rats consuming the other
two diets (0.13±0.05, 1.2±0.4, 6.2±2.7/day, low, medium and
high LNA diet, respectively, Pb0.05), and the half-life of EPA was
longer for rats consuming the low LNA diet compared to thoseconsuming the medium and high LNA diets (19.8±8.6, 4.3±2.4,
0.2±0.09 days, low, medium and high LNA diet, respectively,
Pb0.05).
3.7. n-6 PUFA synthesis–secretion coefficients, rates, turnover rates and
half-life
13C18-ARA was the only n-6 PUFA that was synthesized from
13C18-LNA and detected in the plasma by LC-MS/MS. Therefore, ARA
was the only n-6 PUFA for which synthesis parameters could be
calculated (Table 2). 13C18-ARA was not detected in three rats (one
per dietary group). Daily ARA synthesis rates were calculated to be
higher in rats fed the high and medium LNA diet compared to those
Fig. 4. Example infusion curves and chromatograms (inserts) for a rat. (A) Plasma volume (ml) × concentration of esteriﬁed 2H-EPA (nmol) plotted against time (min) and ﬁt to a
sigmoidal curve. (B) Plasma volume (ml)× concentration of esteriﬁed2H-DHA (nmol) plotted against time (min) andﬁt to a sigmoidal curve. (C) Plasma volume (ml)× concentration of
esteriﬁed13C-ARA (nmol) plotted against time (min) and ﬁt to a sigmoidal curve. This ﬁgure shows the resulting infusion curve for one rat from thatwas infusedwith unesteriﬁed [2H5]-
ALA and [U-13C]-LNA for 3 h. Inserts show chromatograms for the labeled fatty acid measured for each point on the infusion curve. The chromatograms are overlaid in the insert to
illustrate the increase in the amount of the labeled fatty acids throughout the infusion. Arrows indicate the time-point on the infusion curve that corresponds to each peak.
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20.3 nmol/day, low, medium and high LNA diet, respectively,
Pb0.05). Daily ARA synthesis rates were not different in rats fed the
medium LNA diet compared to either the high LNA diet. Rats fed the
high LNA diet had signiﬁcantly faster ARA turnover (0.4±0.1N0.04±
0.01/day, Pb0.05) and shorter ARA half-life (2.2±0.6b27.6±8.3 days,
Pb0.05) compared to rats fed the low LNA diet. ARA turnover and
half-life in rats fed the medium LNA diet did not differ from rats fed the
other two diets (0.4±0.2/day and 9.4±5.0 days for turnover and half-
life, respectively).
3.8. Liver fatty acyl-coA concentrations
Acyl-CoA concentrations were measured for unlabeled ALA-CoA,
EPA-CoA, DHA-CoA, LNA-CoA and ARA-CoA (Table 3). ALA-CoATable 2
Kinetic parameters for synthesis–secretion of DHA, EPA and ARA following 3 h steady-state in
Fatty acid, i Diet Smax,i (nmol/min) K1,i (ml/min)
DHA Low (n=7) 0.02±0.005a 0.01±0.002a
Medium (n=7) 0.09±0.03b 0.02±0.007b
High (n=4) 0.09±0.02b 0.02±0.06ab
EPA Low (n=7) 0.17±0.05 0.06±0.01
Medium (n=7) 0.34±0.10 0.09±0.03
High (n=4) 0.27±0.05 0.06±0.01
ARA Low (n=6) 0.02±0.008a 0.001±0.004a
Medium (n=5) 0.15±0.07b 0.06±0.03b
High (n=3) 0.06±0.01ab 0.03±0.002ab
Data are mean±S.E.M. Differences between diets were measured by one-way ANOVA followed
transformed and then analyzed by one-way ANOVA followed by Tukey's multiple comparisonconcentrations in the livers were not signiﬁcantly different between
dietary groups (3.9±2.0, 4.4±1.3, 4.2±1.5 nmol/g liver, low,
medium and high LNA diets, respectively). EPA-CoA concentrations
were higher in rats fed the low LNA diet compared to the high LNA
diet, but rats fed the medium LNA diet had EPA-CoA concentrations
that were not different from the other dietary groups (86.1±49, 31.4±
21.7, 3.1±1.5 nmol/g liver low, medium and high LNA diet, respective-
ly). DHA-CoA concentrations (49.3±23.2, 29.2±9.2, 9.0±2.0 nmol/g
liver low, medium and high LNA diet, respectively) and ARA-CoA
concentrations (92.3±36.7, 94.9±15.4, 95.1±17.7 nmol/g liver,
low, medium and high LNA diet, respectively) did not differ between
dietary groups. LNA-CoA concentrations were highest in rats fed the high
LNAdiet compared to those fed the lowandmediumLNAdiets (18.4±4.1,
29.9±5.9, 100.1±35.9 nmol/g liver, low, medium and high LNA
diet, respectively).fusion of [2H5]-ALA and [U-13C]-LNA in rats fed a low, medium or high LNA diet.
Daily Synthesis Rate (nmol/day) Fi (/day) t1/2,i (day)
66.7±20.3a 0.03±0.02a 65.0±15.5a
320.5±135.8ab 0.17±0.09b 12.4±4.0b
369.7±91.3b 0.17±0.06b 7.0±3.3b
472.6±186.3 0.13±0.05a 19.8±8.6a
1139±423.2 1.2±0.4b 4.3±2.4b
1278±485.9 6.2±2.7b 0.2±0.09b
101.3±20.3a 0.04±0.01a 27.6±8.3a
3665.0±1907.3b 0.4±0.2ab 9.4±5.0ab
5891.3±1549.6b 0.4±0.1b 2.2±0.6b
by Tukey's multiple comparison test. Data that were not normally distributed were log-
test. Different letters signify that means are signiﬁcantly different (Pb0.05).
Table 3
Liver fatty acid CoA concentrations (nmol/g liver) for rats fed the low, medium or high LNA diet.
Diet [ALA-CoA] (nmol/g) [EPA-CoA] (nmol/g) [DHA-CoA] (nmol/g) [LNA-CoA] (nmol/g) [ARA-CoA] (nmol/g)
Low (n=5) 3.9±2.0 86.1±49.0a 49.3±23.2 18.4±4.1a 92.3±36.7
Medium (n=6) 4.4±1.3 31.4±21.7ab 29.2±9.2 29.9±5.9a 94.9±15.4
High (n=3) 4.1±1.5 3.1±1.5b 9.0±2.0 100.1±35.9b 95.1±17.7
Data are mean±S.E.M. Differences between diets were measured by one-way ANOVA followed by Tukey's multiple comparison. Data that were not normally distributed were log-
transformed and then analyzed by one-way ANOVA followed by Tukey's multiple comparison test. Different letters signify that means are signiﬁcantly different (Pb0.05).
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Hepatic concentrations of 2H5-ALA (Table 4) were signiﬁcantly
lower in rats fed the low LNA diet compared to those fed the high and
medium LNA diet (88.5±13.1, 161.0±18.2, 180.6±16.5 nmol/g low,
medium and high LNA diet, respectively, Pb0.05). Concentration of
2H5-EPA was higher in the liver of rats fed the low and medium LNA
diets as compared to rats fed the high LNA diet (212.6±28.3, 153.6±
24.3, 70.0±22.7 nmol/g, low, medium and high LNA diets, respec-
tively, Pb0.05).
4. Discussion
We found that rats fed a diet low in LNA had lower plasma
esteriﬁed lipid concentrations of LNA and ARA and higher plasma
concentrations of EPA compared to rats fed diets with higher levels of
LNA. This is consistent with ﬁndings of others comparing diets with
high and low amounts of n-6 PUFA in humans and rats [22,28,29].
Previouswork has also shown that feeding diets with low levels of n-6
PUFA will result in higher concentrations of DHA in the plasma [22]
and rat brain [28] and providing dietary ALA as part of a dairy fat blend
leads to higher concentrations of DHA in the brains of rats compared to
those fed the same amount of ALA in a vegetable oil blend containing
higher amounts of LNA [30], suggesting that consuming high levels of
LNA impairs brain DHA accretion [22,23]. We failed to detect a
difference in plasma DHA concentrations; however, there was a trend
toward increased plasmaDHA in rats consuming the low LNAdiet (P=
0.07, t test low vs. medium LNA diet).
n-6 PUFA compete with n-3 PUFA for enzymes involved in the
synthesis of long chain PUFA [13]; therefore, a logical explanation for
the decrease in plasma long chain n-3 PUFA in rats fed high levels of
LNA (observed in this report as well as by others [22]) is decreased
DHA synthesis from ALA. Alternatively, a decrease in plasma DHA can
also be explained by an increased turnover of DHA in the plasma,
without an increase in theDHA synthesis rate.Weperformed a steady-
state infusion of stable-isotope-labeled ALA and LNA to measure the
EPA, DHA and ARA synthesis rates in rats fed diets containing different
levels of LNA. We found that rats fed a diet with low dietary LNA had
signiﬁcantly lower EPA and DHA synthesis–secretion rates as well as
lower K1,DHA compared to rats fed higher levels of LNA. Using the
calculated synthesis–secretion rates and the plasma concentrations of
the different PUFA, the plasmahalf-life of longer chain PUFA from their
dietary precursor (LNA or ALA) can be estimated. We calculated that
rats fed a low level of LNA had longer half-lives for EPA and DHA in the
plasma than rats fed a diet containinghigh levels of LNA. Therefore, the
higher concentration of EPA (and trend toward higher DHA) observedTable 4
Liver 2H5-labeled n-3 PUFA and 13C18-labeled n-6 PUFA concentrations (nmol/g liver) for rats
Diet [2H5-ALA] (nmol/g) [2H5-EPA] (nmol/g) [2
Low (n=7) 88.5±13.1a 212.6±28.3a 1
Medium (n=7) 161.0±18.2b 153.6±24.3a 2
High (n=4) 180.6±16.5b 70.0±22.7b 1
Data are mean±S.E.M. Differences between diets were measured by one-way ANOVA followe
transformed and then analyzed by one-way ANOVA followed by Tukey's multiple comparisonin the plasma esteriﬁed lipids of rats fed a low LNA-containing diet
appear to be due to lower turnover and longer half-lives of these PUFA
in the plasma and not due to higher synthesis rates of these PUFA.
However, it is important to note that the measure of PUFA turnover
and half-life is not a direct measurement but, rather, is an inferred
estimate of the how quickly a PUFA is replaced by PUFA that is newly
synthesized from precursors (ALA and LNA). Since only the precursor
PUFA are consumed in the diet, it is assumed that plasma concentra-
tions of longer chain PUFA are maintained by synthesis from ALA or
LNA. It is possible that PUFA that are synthesized from ALA are stored
in the adipose (or other tissues) and secreted into the plasma at a later
timemaking the measurement of PUFA turnover used in this study an
overestimate. Therefore, future studies should be conducted utilizing a
more direct method tomeasure the half-lives of PUFA in the plasma in
rats fed diets with different levels of LNA.
Other possible explanations for the lack of effect of dietary LNA on
DHA and EPA synthesis rates are tracer dilution in the liver and
inability of rats fed the low LNAdiet to secrete n-3 PUFA from the liver.
Though our experimental procedure did not allow for a proper
measurement of the labeled acyl-CoA pool, we were able to measure
nonlabeled n-3 and n-6 PUFA concentrations in the acyl-CoA pool.
EPA-CoA and LNA-CoA were the only fatty acyl-CoA that differed
between the three dietary groups, so it is unlikely that there were
signiﬁcant differences in tracer dilution between the three dietary
groups in this study. Moreover, while diet altered the concentrations
of ALA in the liver total lipids, hepatic ALA-CoA concentration was
unaffected. Still, future studies that utilize the steady-state infusion
method for measuring DHA synthesis rates should euthanize rats and
collect livers in such amanner as to preserve the labeled fatty acyl-CoA
concentrations in order to properly measure tracer dilution in the
liver. Moreover, it is possible that rats fed the low LNA diet have high
n-3 PUFA synthesis but impaired secretion of these products from the
liver. We assessed this hypothesis by measuring the concentrations of
labeled n-3 PUFA and n-6 PUFA in the livers of rats fed these diets
(Table 4). Therewas no difference in the concentration of labeled DHA
or ARA in rats fed either diet. Therefore, the low DHA synthesis–
secretion rates in rats fed the low LNA diet are not likely due to
impaired DHA secretion.
We also measured ARA and DPAn-6 synthesis rates using the
steady-state infusion method (Table 2). We were unable to detect
labeled DPAn-6 in the plasma and, therefore, could not determine a
synthesis rate. Rats fed the low LNA diet had lower ARA synthesis–
secretion rates than rats fed the diets containing higher levels of LNA,
as would be expected by the higher plasma ARA concentrations in the
plasma in these rats.We found thatwere no differences inK1,ARA in rats
fed the high and low LNA diet; however, K1,ARA was higher in rats fedfed the low, medium or high LNA diet.
H5-DHA] (nmol/g) [13C18-LNA] (nmol/g) [13C18-ARA] (nmol/g)
1.8±3.6 308.9±49.0 4.9±1.1
2.5±3.4 221.2±27.6 7.0±0.4
7.3±6.0 151.3±16.6 5.1±1.5
d by Tukey's multiple comparison. Data that were not normally distributed were log-
test. Different letters signify that means are signiﬁcantly different (Pb0.05).
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Therefore, the similar plasma ARA concentrations between rats
consuming the medium and high LNA diet were maintained by two
differentmechanisms, increased substrate (LNA) availability in the high
LNA group and increased synthesis capacity (K1,ARA) in themediumLNA
group. Moreover, the low LNA diet group did not seem to adapt to a
lower substrate availability as K1,ARA was lowest in rats consuming this
diet (compared the rats consuming the medium LNA diet).
One of the limitations to this study were the small and uneven
sample sizes. While we initially ordered an equal number of rats for
each diet, some rats died throughout the study due to surgical
complications likely brought about by the lack of use of anticoagulants
during the surgery. Therefore, the uneven sample sizes of animals fed
each diet was likely due to chance, and future studies should attempt
to use an anticoagulant, particularly one that does not alter
unesteriﬁed fatty acid concentrations, to prevent surgical complica-
tions. In addition, in some rats, the appearance curves cannot be ﬁt to a
sigmoidal curve (n=1, 1, 2 low, medium, high, respectively, for DHA
appearance and n=2, 2, 3 low, medium, high, respectively, for ARA
appearance), and these animals could not be included in the analysis.
Throughout the 20th century, consumption of LNA has increased
almost threefold in the US and other western diets leading to
an increase in the dietary LNA-to-ALA ratio [17,31]. Moreover, global
n-6 PUFA consumption makes up approximately 6% of energy intake
[32]. An increased ratio of LNA to ALA can possibly lead to decreased
levels of DHA being synthesized because of increased competition for
the desaturase and elongase enzymes involved in DHA synthesis. In
our study, rats were fed diets with LNA levels ranging from 1.5 to 50%
of the fatty acids, and higher dietary LNA levels were associated with
higher EPA and DHA synthesis rates. Therefore, this work indicates
that high levels of LNA may not impair DHA synthesis. However, this
hypothesis should be tested in humans, as it is possible that DHA
synthesis rates in humans are affected differently than rats to high
levels of dietary LNA.
In conclusion, we found that rats fed diets containing high levels of
LNA had increased plasma ARA and decreased plasma EPA concentra-
tions compared to rats fed diets with low levels of LNA. Plasma ARA
concentrations were elevated in rats fed high levels of LNA, likely as a
result of higherARA synthesis rates.However, the augmentedplasman-
3 PUFAconcentrations appear tobedue to decreasedn-3 PUFA turnover
in the plasma rather than increased synthesis–secretion from ALA.Acknowledgements
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